Table 1 Baseline characteristics of the study patients.
From: Real-world data analysis of patients with cancer of unknown primary
Characteristics | Total (n = 218) | |
|---|---|---|
Sex | ||
Male | 136 (62.4) | |
Female | 82 (37.4) | |
Age | ||
≥ 60 | 93 (42.5) | |
< 60 | 125 (57.3) | |
ECOG performance status | ||
0, 1 | 142 (65.1) | |
≥ 2 | 76 (34.7) | |
NGS | 22 (10.1) | |
Disease extent | ||
Localized disease | 33 (15.1) | |
Lymph nodesa | 17 (51.5) | |
Intra-abdominal, pelvis mass | 5 (15.2) | |
Bone | 2 (6.1) | |
Liver | 2 (6.1) | |
Mediastinal mass | 2 (6.1) | |
Peritoneum carcinomatosis alone | 2 (6.1) | |
Extremity | 1 (3.0) | |
Head and neck lesion | 1 (3.0) | |
Intestine | 1 (3.0) | |
Disseminated disease | 185 (84.9) | |
Lymph nodes | 148 (80) | |
Bone | 86 (46.4) | |
Liver | 74 (40) | |
Intra-abdominal organ except liverb | 50 (27) | |
Lung | 50 (27) | |
Peritoneum | 35 (18.9) | |
Pleural effusion | 19 (10.2) | |
Adrenal gland | 15 (8.1) | |
Brain | 7 (3.7) | |
Head and neck lesion | 7 (3.7) | |
Muscle | 5 (2.7) | |
Skin | 4 (2.1) | |
